![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Preclinical Drug Discovery, Cardiovascular & Urogenital Centre of Excellence in Drug Discovery, GlaxoSmithKline, King of Prussia, Pennsylvania
This study was conducted to comprehensively survey the available literature on intravenous pharmacokinetic parameters in the rat, dog, monkey, and human, and to compare common methods for extrapolation of clearance, to identify the most appropriate species to use in pharmacokinetic lead optimization, and to ascertain whether adequate prospective measures of predictive success are currently available. One hundred three nonpeptide xenobiotics were identified with intravenous pharmacokinetic data in rat, dog, monkey, and human; both body weight- and hepatic blood flow-based methods were used for scaling of clearance. Allometric scaling approaches, particularly those using data from only two of the preclinical species, were less successful at predicting human clearance than methods based on clearance as a set fraction of liver blood flow from an individual species. Furthermore, commonly used prospective measures of allometric scaling success, including correlation coefficient and allometric exponent, failed to discriminate between successful and failed allometric predictions. In all instances, the monkey tended to provide the most qualitatively and quantitatively accurate predictions of human clearance and also afforded the least biased predictions compared with other species. Additionally, the availability of data from both common nonrodent species (dog and monkey) did not ensure enhanced predictive quality compared with having only monkey data. The observations in this investigation have major implications for pharmacokinetic lead optimization and for prediction of human clearance from in vivo preclinical data and support the continued use of nonhuman primates in preclinical pharmacokinetics.
This article has been cited by other articles:
|
|
 |
|
  N. A. Hosea, W. T. Collard, S. Cole, T. S. Maurer, R. X. Fang, H. Jones, S. M. Kakar, Y. Nakai, B. J. Smith, R. Webster, et al. Prediction of Human Pharmacokinetics From Preclinical Information: Comparative Accuracy of Quantitative Prediction Approaches J. Clin. Pharmacol., May 1, 2009; 49(5): 513 - 533. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Horvath and M. N. Milton The TeGenero Incident and the Duff Report Conclusions: A Series of Unfortunate Events or an Avoidable Event? Toxicol Pathol, April 1, 2009; 37(3): 372 - 383. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ogasawara, M. Utoh, K. Nii, A. Ueda, T. Yoshikawa, T. Kume, and K. Fukuzaki Effect of Oral Ketoconazole on Oral and Intravenous Pharmacokinetics of Simvastatin and Its Acid in Cynomolgus Monkeys Drug Metab. Dispos., January 1, 2009; 37(1): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Goteti, P. J. Brassil, S. S. Good, and C. E. Garner Estimation of Human Drug Clearance Using Multiexponential Techniques J. Clin. Pharmacol., October 1, 2008; 48(10): 1226 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Obach, F. Lombardo, and N. J. Waters Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds Drug Metab. Dispos., July 1, 2008; 36(7): 1385 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Ward, D. J. Coon, D. Magiera, S. Bhadresa, E. Nisbett, and M. S. Lawrence Exploration of the African Green Monkey as a Preclinical Pharmacokinetic Model: Intravenous Pharmacokinetic Parameters Drug Metab. Dispos., April 1, 2008; 36(4): 715 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tang, A. Hussain, M. Leal, M. Mayersohn, and E. Fluhler Interspecies Prediction of Human Drug Clearance Based on Scaling Data from One or Two Animal Species Drug Metab. Dispos., October 1, 2007; 35(10): 1886 - 1893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nishimura, N. Amano, Y. Kubo, M. Ono, Y. Kato, H. Fujita, Y. Kimura, and A. Tsuji Asymmetric Intestinal First-Pass Metabolism Causes Minimal Oral Bioavailability of Midazolam in Cynomolgus Monkey Drug Metab. Dispos., August 1, 2007; 35(8): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhou, P. Guo, G. D. Kruh, P. Vicini, X. Wang, and J. M. Gallo Predicting Human Tumor Drug Concentrations from a Preclinical Pharmacokinetic Model of Temozolomide Brain Disposition Clin. Cancer Res., July 15, 2007; 13(14): 4271 - 4279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ogasawara, T. Kume, and E. Kazama Effect of Oral Ketoconazole on Intestinal First-Pass Effect of Midazolam and Fexofenadine in Cynomolgus Monkeys Drug Metab. Dispos., March 1, 2007; 35(3): 410 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Evans, L. J. Jolivette, R. Nagilla, and K. W. Ward EXTRAPOLATION OF PRECLINICAL PHARMACOKINETICS AND MOLECULAR FEATURE ANALYSIS OF "DISCOVERY-LIKE" MOLECULES TO PREDICT HUMAN PHARMACOKINETICS Drug Metab. Dispos., July 1, 2006; 34(7): 1255 - 1265. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tahara, H. Kusuhara, M. Chida, E. Fuse, and Y. Sugiyama Is the Monkey an Appropriate Animal Model to Examine Drug-Drug Interactions Involving Renal Clearance? Effect of Probenecid on the Renal Elimination of H2 Receptor Antagonists J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1187 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. A. Brightman, D. E. Leahy, G. E. Searle, and S. Thomas APPLICATION OF A GENERIC PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL TO THE ESTIMATION OF XENOBIOTIC LEVELS IN HUMAN PLASMA Drug Metab. Dispos., January 1, 2006; 34(1): 94 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tang and M. Mayersohn A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE Drug Metab. Dispos., September 1, 2005; 33(9): 1294 - 1296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Ward and B. R. Smith A COMPREHENSIVE QUANTITATIVE AND QUALITATIVE EVALUATION OF EXTRAPOLATION OF INTRAVENOUS PHARMACOKINETIC PARAMETERS FROM RAT, DOG, AND MONKEY TO HUMANS. II. VOLUME OF DISTRIBUTION AND MEAN RESIDENCE TIME Drug Metab. Dispos., June 1, 2004; 32(6): 612 - 619. [Abstract] [Full Text] [PDF]
|
|
Read all eLetters
 |
 |
 |
|
 |
 |
 |
